You are here: Industry Insights > COVID-19

News List

Indoco launches favipiravir 400 mg tablets expresspharma
September 28, 2020
Fevindo - 400 will be made available at all government approved COVID care centres and selected medical practitioners across the country.
Johns Hopkins researchers publish COVID-19 'prediction model' worldpharmanews
September 27, 2020
Using a combination of demographic and clinical data gathered from seven weeks of COVID-19 patient care early in the coronavirus pandemic, Johns Hopkins researchers published a "prediction model" they say can help other hospitals care for COVID-19 ...
Scientists trace severe COVID-19 to faulty genes and an autoimmune condition worldpharmanews
September 27, 2020
More than 10 percent of young and healthy people who develop severe COVID-19 have misguided antibodies that attack not the virus, but the immune system itself, new research shows. Another 3.5 percent, at least, carry a specific kind of genetic mutation.
Adequate levels of vitamin D reduces complications, death among COVID-19 patients worldpharmanews
September 27, 2020
Hospitalized COVID-19 patients who were vitamin D sufficient, with a blood level of 25-hydroxyvitamin D of at least 30 ng/mL (a measure of vitamin D status), had a significant decreased risk for adverse clinical outcomes including becoming unconscious ...
UK consumers seeking advice from pharmacists during pandemic, research finds pharmatimes
September 27, 2020
New research from Ipsos MORI has found that UK consumers have turned to community pharmacists during COVID-19 for healthcare advice and more.
Fujifilm to seek approval for Avigan in Covid-19 after positive data pharmaceutical-technology
September 27, 2020
Japan’s Fujifilm Toyama Chemical plans to seek approval for its anti-viral drug Avigan (favipiravir) to treat patients with Covid-19, after obtaining positive results in Phase III clinical trial.
CEBINA Reports Positive Findings on Azelastine Potency for COVID-19 americanpharmaceuticalreview
September 27, 2020
CEBINA GmbH has announced further positive results in its collaborative COVID-19 drug repurposing project, demonstrating allergy nasal spray medication containing azelastine has potent efficacy against SARS-CoV-2 in a human 3D nasal tissue model.
Rigel Announces NIH/NHLBI-Sponsored Trial of Fostamatinib in Hospitalized COVID-19 Patients americanpharmaceuticalreview
September 27, 2020
Rigel Pharmaceuticals announced the start of a multicenter, Phase 2 trial to evaluate the safety of fostamatinib, its oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of hospitalized COVID-19 patients.
Ortho Awarded Contract to Accelerate Antigen Test Development americanpharmaceuticalreview
September 27, 2020
Ortho Clinical Diagnostics announced its continued collaboration with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and ...
Herd immunity is an impractical COVID-19 mitigation strategy, says study europeanpharmaceuticalreview
September 27, 2020
Researchers who designed a transmission model for COVID-19 demonstrated that attempting to establish herd immunity against COVID-19 would be too challenging.